Boston Scientific has entered into a definitive agreement to buy a developer of-gener nextation mapping and navigation systems, Rhythmia Medical. US based Rhythmia Medical's mapping and navigation technologies are used with catheter ...
Tags: mapping and navigation system, acquisition, clinical technology
Boston Scientific, a provider of cardiovascular implants, has completed enrolling patients in its Prevail confirmatory study. The CE-marked self-expanding nitinol frame Watchman device, placed in the left atrial appendage (LAA) via the ...
Tags: Boston Scientific, cardiovascular implants, Prevail confirmatory study
The European Union (EU) has granted CE mark to Boston Scientific's deep brain stimulator to treat Parkinson's disease. The Vercise deep brain stimulator, which includes multiple independent current control, uses electrical signals to ...
Tags: Parkinson, Vercise, deep brain stimulator, Wurzburg neurology department
Boston Scientific has received CE mark approval for an expanded indication of Watchman Left Atrial Appendage (LAA) Closure device, designed to capture any clots that may form in the appendage. The Watchman device also reduces the risk of ...
Tags: CE mark approval, Watchman Device
The US Food and Drug Administration (FDA) has cleared Boston Scientific's subcutaneous implantable cardioverter defibrillator (S-ICD) to treat patients at risk for sudden cardiac arrest (SCA). The CE-marked system, which the company ...
Tags: FDA, CE-marked system, S-ICD system
Boston Scientific has obtained CE mark approval for its spinal cord stimulator(SCS)system with 32 contacts and 32 dedicated power sources. The Precision Spectra system,which has four lead ports offering more coverage of the spinal cord,is ...
Tags: Boston Scientific, CE mark approval, SCS system, spinal cord
Boston Scientific has completed enrolling first patient in a EVOLVE II clinical trial of its Synergy Everolimus-Eluting platinum chromium coronary stent system. The CE-marked stent features a combination of everolimus drug and ...
Tags: Synergy Everolimus Eluting platinum chromium coronary stent system
Boston Scientific has obtained the CE mark approval for the extended longevity provided by its INCEPTA, ENERGEN, PUNCTUA, COGNIS and TELIGEN implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators ...